Sigma is a leading Australian full line wholesale and distribution business to pharmacy.
The planned exit of the CW business and the significant transformation undertaken subsequently meant the current year reported financial performance was always going to be challenging. While our underlying business is performing strongly, these factors have impacted Reported Earnings.
The past 12 months have been a period of significant transformational change for our business.
Importantly, our core business has
continued to build momentum towards
the end of the current financial year.
CEO and MD's Report
The Sigma business continues to evolve through our transformation program. We have invested in capacity, realigned our organisational structure, and empowered our teams to drive our customer-centric approach. This is an enterprise-wide strategy that is seeing encouraging results from an engaged team.